MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines

By on    Picture Gallery, Software  

MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines

LOS ANGELES, CA — (Marketwired) — 10/02/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that two additional patents will be granted for its B-cell vaccine technologies. MMR has been notified it will receive another U.S. patent protecting methods of making compositions for B-cell vaccines pursuant to a Notice of Allowance from the United States Patent and Trademark Office. The

MMRGlobal Targets Phase 3 Biotech Companies to Combine Assets With Life Sciences Group

By on    Internet, Picture Gallery  

MMRGlobal Targets Phase 3 Biotech Companies to Combine Assets With Life Sciences Group

LOS ANGELES, CA — (Marketwire) — 11/19/12 — (OTCBB: MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its pipeline of biotech assets by facilitating a partnership or other joint venture with a privately held biotech company that has completed its Phase 2 clinical trials and is in the process of beginning Phase 3. The Company has held talks with several privately held biotech companies who are finding it difficult to get